Association between ablation technology and asymptomatic cerebral injury following atrial fibrillation ablation

Liu Guijian1, Zhu Wenqing, Wang Xinggang

  • 1Key Laboratory of Viral Heart Diseases, Ministry of Public Health, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

Abstract

Insights

Asymptomatic cerebral injury (ACI) after atrial fibrillation (AF) ablation occurs in 15.9% of patients. Pulmonary Vein Ablation Catheter (PVAC) use was linked to higher ACI incidence, while uninterrupted anticoagulation may reduce risk.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Imaging

Background:

  • Asymptomatic cerebral injury (ACI) is increasingly detected by diffusion-weighted magnetic resonance imaging (MRI) after atrial fibrillation (AF) ablation.
  • Understanding the incidence and risk factors for ACI is crucial for patient safety and procedural optimization.

Purpose of the Study:

  • To systematically review and quantify the incidence of ACI following AF ablation.
  • To explore the association between different ablation technologies and the occurrence of ACI.

Main Methods:

  • A systematic literature search was conducted across PubMed, Web of Science, and Cochrane Library Databases.
  • Data on ACI incidence, odds ratios, and confidence intervals were pooled from 21 eligible studies.
  • Subgroup analysis was performed to compare ACI rates across various ablation technologies.

Main Results:

  • The overall incidence of ACI detected by MRI following AF ablation was 15.9%.
  • Incidence varied by technology: irrigated radiofrequency (RF) (13.0%), multielectrode-phased RF pulmonary vein ablation catheter (PVAC) (27.6%), cryoballoon (12.5%), laser balloon (17.3%), and nMARQTM (32.6%).
  • Higher ACI incidence was observed with PVAC compared to other technologies.

Conclusions:

  • PVAC technology is associated with a higher incidence of ACI post-AF ablation.
  • Maintaining uninterrupted oral anticoagulation (OAC) during the procedure may reduce ACI incidence.
  • Standardized MRI diagnostic criteria for silent cerebrovascular ischemia are needed for future research.